Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A possible genetic association between obesity and colon cancer in females. | Front Endocrinol (Lausanne) | 2023 | 37711894 | PubTator, text mining | PubMed |
| LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1. | Int J Biol Sci | 2023 | 37705754 | PubTator, text mining | PubMed |
| Determinants of response to CDK4/6 inhibitors in the real-world setting. | NPJ Precis Oncol | 2023 | 37704753 | PubTator, text mining | PubMed |
| Prognostic value of cell division cycle-associated protein-3 in prostate cancer. | Medicine (Baltimore) | 2023 | 37682152 | PubTator, text mining | PubMed |
| The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review. | Medicine (Baltimore) | 2023 | 37682144 | PubTator, text mining | PubMed |
| Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients. | Front Cell Dev Biol | 2023 | 37675143 | PubTator, text mining | PubMed |
| Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature. | Front Immunol | 2023 | 37671160 | PubTator, text mining | PubMed |
| Massively Parallel Reporter Assay Confirms Regulatory Potential of hQTLs and Reveals Important Variants in Lupus and Other Autoimmune Diseases. | bioRxiv | 2023 | 37645944 | PubTator, text mining | PubMed |
| PIWIL2 restrains the progression of thyroid cancer via interaction with miR-146a-3p. | BMC Endocr Disord | 2023 | 37641092 | PubTator, text mining | PubMed |
| Mutations in CCNB3 affect its location thus causing a multiplicity of phenotypes in human oocytes maturation by aberrant CDK1 activity and APC/C activity at different stages. | J Ovarian Res | 2023 | 37635245 | PubTator, text mining | PubMed |
| Cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis. | Int J Mol Sci | 2023 | 37628927 | PubTator, text mining | PubMed |
| Pseudogenes in Cancer: State of the Art. | Cancers (Basel) | 2023 | 37627052 | PubTator, text mining | PubMed |
| MiR-520d-3p suppresses the proliferation and epithelial-mesenchymal transition of cervical cancer cells by targeting ZFP36L2. | Heliyon | 2023 | 37600385 | PubTator, text mining | PubMed |
| Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis. | Cell Death Differ | 2023 | 37596441 | PubTator, text mining | PubMed |
| Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. | Front Immunol | 2023 | 37593739 | PubTator, text mining | PubMed |
| Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha. | Front Immunol | 2023 | 37588598 | PubTator, text mining | PubMed |
| Lactic control of tumor growth: a new role for an old metabolite. | Signal Transduct Target Ther | 2023 | 37587111 | PubTator, text mining | PubMed |
| Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. | Front Immunol | 2023 | 37583701 | PubTator, text mining | PubMed |
| High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation. | J Cancer | 2023 | 37576392 | PubTator, text mining | PubMed |
| The APC/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer. | Cell Death Dis | 2023 | 37573356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=11